- Home
- PLBC vs MXCT Comparison
PLBC vs MXCT Comparison
Compare PLBC & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBC
- MXCT
- Stock Information
- Founded
- PLBC 1980
- MXCT 1999
- Country
- PLBC United States
- MXCT United States
- Employees
- PLBC N/A
- MXCT N/A
- Industry
- PLBC Finance Companies
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PLBC Finance
- MXCT Health Care
- Exchange
- PLBC Nasdaq
- MXCT Nasdaq
- Market Cap
- PLBC 236.7M
- MXCT 275.7M
- IPO Year
- PLBC 2005
- MXCT 2021
- Fundamental
- Price
- PLBC $43.93
- MXCT $2.36
- Analyst Decision
- PLBC Buy
- MXCT Strong Buy
- Analyst Count
- PLBC 3
- MXCT 1
- Target Price
- PLBC $57.67
- MXCT $9.00
- AVG Volume (30 Days)
- PLBC 14.9K
- MXCT 734.8K
- Earning Date
- PLBC 04-16-2025
- MXCT 05-07-2025
- Dividend Yield
- PLBC 2.75%
- MXCT N/A
- EPS Growth
- PLBC 3.33
- MXCT N/A
- EPS
- PLBC 4.95
- MXCT N/A
- Revenue
- PLBC $84,001,000.00
- MXCT $37,675,000.00
- Revenue This Year
- PLBC $19.95
- MXCT $9.05
- Revenue Next Year
- PLBC $22.19
- MXCT $19.98
- P/E Ratio
- PLBC $8.80
- MXCT N/A
- Revenue Growth
- PLBC 9.14
- MXCT N/A
- 52 Week Low
- PLBC $32.50
- MXCT $2.21
- 52 Week High
- PLBC $51.33
- MXCT $5.26
- Technical
- Relative Strength Index (RSI)
- PLBC 56.06
- MXCT 33.78
- Support Level
- PLBC $42.41
- MXCT $2.60
- Resistance Level
- PLBC $45.77
- MXCT $2.86
- Average True Range (ATR)
- PLBC 1.55
- MXCT 0.15
- MACD
- PLBC 0.24
- MXCT -0.02
- Stochastic Oscillator
- PLBC 62.75
- MXCT 9.77
About PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.